Status:

RECRUITING

Use of a Decision Aid to Resolve Uncertainty About Radioactive Iodine Treatment in Patients With Intermediate Risk Thyroid Cancer

Lead Sponsor:

Georgetown University

Collaborating Sponsors:

National Institutes of Health (NIH)

National Institute of Dental and Craniofacial Research (NIDCR)

Conditions:

Thyroid Cancer

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The goal of this study is to learn if a decision aid (DA) website helps people with thyroid cancer make informed decisions about radioactive iodine (RAI) treatment. The main questions it aims to answe...

Detailed Description

Background Information Differentiated thyroid cancer (DTC) presents with a spectrum of disease severity, which is associated with varying recurrence rates. Radioactive iodine (RAI) treatment is often ...

Eligibility Criteria

Inclusion

  • Patients aged 18 and older
  • Patients diagnosed with intermediate risk DTC \< 6 months ago and who are making a decision about RAI treatment
  • Ability to understand the information conveyed in the informed consent form, pose questions and process answers (e.g., no cognitive impairment per direct consultation with the patient's physician), and, finally, provided informed consent to participate.
  • Participants willingness to be contacted and remain available to complete study activities throughout the duration of the study.

Exclusion

  • Diagnosis of low risk or high risk DTC
  • Prior history of RAI
  • Clinical contraindications that prevent consideration of RAI (e.g., pregnancy, lactation, neutropenia if considering high dose of RAI)

Key Trial Info

Start Date :

August 6 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 31 2029

Estimated Enrollment :

408 Patients enrolled

Trial Details

Trial ID

NCT06980103

Start Date

August 6 2025

End Date

July 31 2029

Last Update

January 8 2026

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Lombardi Comprehensive Cancer Center

Washington D.C., District of Columbia, United States, 20007

2

MedStar Washington Hospital Center

Washington D.C., District of Columbia, United States, 20010

3

Inova Health System

Falls Church, Virginia, United States, 22031